Tradestie Institutional Equity Comparison Engine

DBVT vs ASMB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ASMB Overall Edge

ASMB Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Assembly Biosciences, Inc (ASMB) driven by superior Valuation, Growth & Margin while DBVT counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, DBVT trades at N/M Forward P/E with -5577.0% operating margin (-42.9% YoY revenue) versus ASMB at N/M Forward P/E and -31.8% operating margin (-72.6% YoY). In options structure, DBVT sits in SURGE (13th %ile IV; Dealer Gamma Walls on Pro) against ASMB sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ASMB
DBVT N/M vs ASMB N/M Fwd P/E
Growth & Margin Winner ASMB
Op Margin -5577.0% vs -31.8% ยท YoY -42.9% vs -72.6%
Momentum & Technical Winner DBVT
1Y -21.4% vs -39.6% ยท 52W Pos 9% vs 11%
Options & Structure Winner DBVT
SURGE (13th %ile IV) vs UNCLASSIFIED (100th %ile IV)
DBVT NASDAQ
DBV Technologies S.A.
Biological Products, (No Disgnostic Substances)
$10.26
-6.85% 1D
Market Cap $682.5M
1M Return +13.37%
1Y Return -21.44%
Forward P/E N/M
Unified AI Score
30.9 / 100 SELL
Tech 15.0 Fund 36.0 Flow 60.0 Mom 40.0
ASMB NASDAQ
Assembly Biosciences, Inc
Pharmaceutical Preparations
$21.46
+1.63% 1D
Market Cap $414.5M
1M Return +6.84%
1Y Return -39.57%
Forward P/E N/M
Unified AI Score
42.6 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DBVT -21.44% ASMB -39.57% Spread: +18.13 pp (DBVT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DBVT TTM Op. Margin: -5577.0% ASMB TTM Op. Margin: -31.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DBVT vs ASMB. Trailing 12-month operating profitability (DBVT -5577.0% vs ASMB -31.8%) and valuation multiples (DBVT N/M vs ASMB N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DBVT (3) vs ASMB (6)
Institutional Metric DBVT ASMB Criterion Row Winner
Market Capitalization Scale $682.5M $414.5M Larger Scale DBVT
Trailing P/E Ratio Valuation N/M 19.6x Lower Multiple ASMB
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -42.9% -72.6% Higher Growth DBVT
Operating Margin (TTM) Profitability -5577.0% -31.8% Higher Margin ASMB
Net Profit Margin Profitability 0.0% -16.6% Higher Margin DBVT
Return on Equity (ROE) Capital Efficiency -205.8% -4.6% Higher ROE ASMB
52-Week Range Position Momentum 9% ($9โ€“$26) 11% ($19โ€“$40) Stronger Trend ASMB
Beta / 30D Volatility Risk Regime 1.17ฮฒ ยท 77% Vol 1.08ฮฒ ยท 59% Vol Lower Realized Risk ASMB
Unified Institutional Score Composite Signal 30.9 / 100 (SELL) 42.6 / 100 (HOLD) Higher Composite ASMB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DBVT vs ASMB Buy Guide
DBVT SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live DBVT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ASMB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live ASMB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DBVT nor ASMB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.